We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
-3.12%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$19.3B
AUM Growth
-$1.05B
(-5.2%)
Cap. Flow
-$77.1M
Cap. Flow
% of AUM
-0.4%
Top 10 Holdings %
Top 10 Hldgs %
26.03%
Holding
1,444
New
138
Increased
405
Reduced
531
Closed
234
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$224M |
| 2 |
Brown-Forman Class B
BF.B
|
+$140M |
| 3 |
UnitedHealth
UNH
|
+$132M |
| 4 |
Monolithic Power Systems
MPWR
|
+$108M |
| 5 |
Oracle
ORCL
|
+$97.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$134M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$122M |
| 3 |
Micron Technology
MU
|
+$122M |
| 4 |
Pfizer
PFE
|
+$120M |
| 5 |
Microsoft
MSFT
|
+$117M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.43% |
| 2 | Healthcare | 14.49% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.92% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
826
Vanda Pharmaceuticals
VNDA
$305M
| $690K | ﹤0.01% |
69,876
-2,000
| -3% | -$21.1K |
|
827
Village Super Market
VLGEA
$634M
| $689K | ﹤0.01% |
35,634
-8,003
| -18% | -$177K |
|
|
KBAL
828
DELISTED
Kimball International
KBAL
| $688K | ﹤0.01% |
109,313
+24,374
| +29% | +$189K |
|
829
Amphenol
APH
$208B
| $686K | ﹤0.01% |
20,494
-45,462
| -69% | -$1.65M |
|
830
PagerDuty
PD
$875M
| $676K | ﹤0.01% |
29,304
+1,471
| +5% | +$38K |
|
|
MRO
831
DELISTED
Marathon Oil Corporation
MRO
| $675K | ﹤0.01% |
+29,913
| New | +$709K |
|
832
Dorian LPG
LPG
$1.96B
| $671K | ﹤0.01% |
49,433
-22,293
| -31% | -$335K |
|
833
Intellia Therapeutics
NTLA
$1.67B
| $668K | ﹤0.01% |
11,943
+1,301
| +12% | +$80.7K |
|
834
Vitamin Cottage Natural Grocers
NGVC
$643M
| $664K | ﹤0.01% |
61,511
| – | – |
|
835
Consensus Cloud Solutions
CCSI
$692M
| $662K | ﹤0.01% |
13,999
-1,949
| -12% | -$100K |
|
836
Costamare
CMRE
$1.74B
| $662K | ﹤0.01% |
73,927
| – | – |
|
837
BioLife Solutions
BLFS
$1.72B
| $661K | ﹤0.01% |
29,070
+220
| +0.8% | +$4.71K |
|
|
FLG
838
Flagstar Bank National Association
FLG
$5.94B
| $661K | ﹤0.01% |
25,837
-4,142
| -14% | -$122K |
|
839
AdvanSix
ASIX
$442M
| $658K | ﹤0.01% |
20,485
-2,157
| -10% | -$77.6K |
|
840
Farmers National Banc Corp
FMNB
$968M
| $658K | ﹤0.01% |
50,257
| – | – |
|
|
EFOR
841
Everforth Inc
EFOR
$1.33B
| $656K | ﹤0.01% |
7,261
-175
| -2% | -$17K |
|
842
HBT Financial
HBT
$1.35B
| $650K | ﹤0.01% |
35,800
| – | – |
|
843
Protagonist Therapeutics
PTGX
$9.95B
| $649K | ﹤0.01% |
76,990
+6,060
| +9% | +$57.3K |
|
844
Crocs
CROX
$6.33B
| $647K | ﹤0.01% |
9,430
-64,433
| -87% | -$4.47M |
|
845
HP
HPQ
$27.7B
| $646K | ﹤0.01% |
25,920
-2,274,559
| -99% | -$69.9M |
|
|
AAN
846
DELISTED
The Aaron's Company Inc
AAN
| $643K | ﹤0.01% |
66,155
-87,061
| -57% | -$1.16M |
|
|
VIA
847
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $642K | ﹤0.01% |
18,567
-652
| -3% | -$25.8K |
|
|
BHVN
848
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $642K | ﹤0.01% |
4,250
-661
| -13% | -$98K |
|
849
Core & Main
CNM
$8.6B
| $637K | ﹤0.01% |
28,016
-6,050
| -18% | -$141K |
|
850
IDT Corp
IDT
$1.65B
| $636K | ﹤0.01% |
25,600
| – | – |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q3 2022 Portfolio in Review
As of Q3 2022, Los Angeles Capital Management held 1,444 positions worth $19.3B, down 5.2% from $20.3B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Los Angeles Capital Management's Q3 2022 filing shows 138 new, 405 increased, 531 reduced and 234 closed positions. Its largest new stake was Neurocrine Biosciences: 791,966 shares worth $84.1M. The largest sale was Alphabet (Google) Class C, an estimated $134M.
By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 32% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q3 2022 buy was Neurocrine Biosciences: 791,966 shares worth $84.1M.
- Los Angeles Capital Management added most to Broadcom in Q3 2022, an estimated $224M increase.
- Los Angeles Capital Management's biggest Q3 2022 reduction was Alphabet (Google) Class C, cutting an estimated $134M.
- Los Angeles Capital Management fully exited D.R. Horton in Q3 2022, selling an estimated $37.1M.
- Los Angeles Capital Management's ten largest holdings make up 26% of its $19.3B portfolio in Q3 2022.
- Los Angeles Capital Management opened 138 new positions and closed 234 in Q3 2022.
- Los Angeles Capital Management's portfolio value fell 5.2% quarter-over-quarter to $19.3B.
Based on Los Angeles Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.